ANTX
NASDAQ · Pharmaceuticals
An2 Therapeutics Inc
$4.00
+0.05 (+1.14%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+363.8% upside
Low Target
$11.23
Average Target
$18.55
High Target
$22.80
Current Price
$4.00
Current
$4.00
$4.00
Target
$18.55
$18.55
$11.23
$18.55 avg
$22.80
Scenario Analysis
Bear Case
$11.23
180.8%
Low target
Base Case
$18.55
+363.8%
Avg target
Bull Case
$22.80
+470.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$7.19
-44.4% from high
52-Week Low
$1.00
+300.0% from low
Target vs 52W High
$18.55
+158.0% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.20
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals